Age-specific changes in the regulation of LH-dependent testosterone secretion: Assessing responsiveness to varying endogenous gonadotropin output in normal men

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 289, Issue 3 58-3, 2005, Pages

  Liu, Peter Y ^a   Takahashi, Paul Y ^a   Roebuck, Pamela D ^a   Iranmanesh, Ali ^b   Veldhuis, Johannes D ^a  

^a MAYO CLINIC   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Aging; Androgen; Gonadotropin releasing hormone; Luteinizing hormone; Male; Secretion

Indexed keywords

ALBUMIN; GANIRELIX; GONADORELIN ANTAGONIST; GONADOTROPIN; LUTEINIZING HORMONE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; AGE; AGED; AGING; ARTICLE; CONTROLLED STUDY; ENDOCRINE SYSTEM; HUMAN; HUMAN EXPERIMENT; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LEYDIG CELL; LINEAR REGRESSION ANALYSIS; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE HORMONE RELEASE; STEROIDOGENESIS; TESTOSTERONE RELEASE;

ADULT; AGED; AGING; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HORMONE ANTAGONISTS; HUMANS; LINEAR MODELS; LUTEINIZING HORMONE; MALE; MIDDLE AGED; PULSATILE FLOW; RECEPTORS, LHRH; REFERENCE VALUES; TESTOSTERONE;

EID: 23944463647     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00138.2005     Document Type: Article

References (67)

1. The Ganivelix Dose-Finding Study Group. A double-blind, randomized, dose-finding study to assess the efficacy of the gonadotrophin-releasing hormone antagonist ganirelix (Org 37462) to prevent premature luteinizing hormone surges in women undergoing ovarian stimulation with recombinant follicle stimulating hormone (Puregon). The ganirelix dose-finding study group. Hum Reprod 13: 3023-3031, 1998.
2. Bonavera JJ, SwerdlolT RS, Sinha Hakim AP, Lue YH, and Wang C. Aging results in attenuated gonadotropin releasing hormone-luteinizing hormone axis responsiveness to glutamate receptor agonist N-methyl-D-aspartate. J Neuroendocrinol 10: 93-99, 1998.
3. Bourguignon JP, Gerard A, and Franchimont P. Age-related difference in the effect of castration upon hypothalamic LHRH content in male rat. Neuroendocrinology. 38: 376-381, 1984.
4. Burgon PG, Stanton PG, and Robertson DM. In vivo bioactivities and clearance patterns of highly purified luteinizing hormone isoforms. Endocrinology 137: 4827-4836, 1996.
5. Chen H and Zirkin BR. Long-term suppression of Leydig cell steroidogenesis prevents Leydig cell aging. Proc Natl Acad Sci USA 96: 14877-14881, 1999.
6. Chubb CE and Desjardins C. Testicular function and neuroendocrine activity in senescent mice. Am J Physiol Endocrinol Metab 247: E410-E415, 1984.
7. Clark AF, Calandra KS, and Bird CK. Kinetics of [3H]-testosterone metabolism in normal young men: effects of medroxyprogesterone acetate (provera) administration. J Steroid Biochem 3: 837-842, 1972.
8. Darney, KJ Jr and Ewing L. Autoregulation of testosterone secretion in perfused rat testes. Endocrinology 109: 993-995, 1981.
9. Davis MR, Veldhuis JD, Rogol AD, Dufau ML, and Catt KJ. Sustained inhibitory actions of a potent antagonist of gonadotropin-releasing hormone in postmenopausal women. J Clin Endocrinol Metab 64: 1268-1274, 1987.
10. Eik-Nes KB. Secretion of testosterone in anesthetized dogs. Endocrinology 71: 101-106, 1962.
11. Feldman HA, Longcope C, Derby CA, Johannes CB, Araujo AB, Coviello AD, Bremner WJ, and McKinlay JB. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 87: 589-598, 2002.
12. Foresta C, Bordon P, Rossato M, Mioni R, and Veldhuis JD. Specific linkages among luteinizing hormone, follicle stimulating hormone, and testosterone release in the peripheral blood and human spermatic vein: evidence for both positive (feed-forward) and negative (feedback) within-axis regulation. J Clin Endocrinol Metab 82: 3040-3046, 1997.
13. Gruenewald DA, Naai MA, Hess DL, and Matsumoto AM. The Brown Norway rat as a model of male reproductive aging: evidence for both primary and secondary testicular failure. J Gerontol R Psychol Sci Soc Sci 49: B42-B50, 1994.
14. Grzywacz FW, Chen H, Allegretti J, and Zirkin BR. Does age-associated reduced Leydig cell testosterone production in Brown Norway rats result from under-stimulation by luteinizing hormone? J Androl 19: 625-630, 1998.
15. Harman SM, Metter FJ, Tobin JD, Pearson J, and Blackman MR. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 86: 724-731, 2001.
16. Harman SM and Tsitouras PD. Reproductive hormones in aging men. I. Measurement of sex steroids, basal luteinizing hormone, and Leydig cell response to human chorionic gonadotropin. J Clin Endocrinol Metab 51: 35-40, 1980.
17. Horton R, Shinsnko J, and Forsham PH. Testosterone production and metabolic clearance rules with volumes of distribution in normal adult men and women. Acta Endocrinol 48: 446-458, 1965.
18. Jarjour LT, Handelsman DJ, and Swerdloff RS. Effects of aging on the in vitro release of gonadotropin-releasing hormone. Endocrinology 119: 1113-1117, 1986.
19. Karpas AE, Bremner WJ, Clifton DK, Steiner RA, and Dorsa DM. Diminished luteinizing hormone pulse frequency and amplitude with aging in the male rat. Endocrinology 112: 788-791, 1983.
20. Keenan DM, Alexander SL, Irvine CHG, Clarke IJ, Canny BJ, Scott CJ, Tilbrook AJ, Turner AI, and Veldhuis JD. Reconstruction of in vivo time-evolving neuroendocrine dose-response properties unveils admixed deterministic and stochastic elements in interglandular signaling. Proc Natl Acad Sci USA 101: 6740-6745, 2004.
21. Keenan DM and Veldhuis JD. Stochastic model of admixed basal and pulsatile hormone secretion as modulated by a deterministic oscillator. Am J Physiol Regul Integr Comp Physiol 273: R1182-R1192, 1997.
22. Keenan DM and Veldhuis JD. A biomathematical model of time-delayed feedback in the human male hypothalamic-pituitary-Leydig cell axis. Am J Physiol Endocrinol Metab 275: E157-E176, 1998.
23. Keenan DM and Veldhuis JD. Disruption of the hypothalamic luteinizing-hormone pulsing mechanism in aging men. Am J Physiol Regul Integr Comp Physiol 281: R1917-R1924, 2001.
24. Keenan DM and Veldhuis JD. Hypothesis testing of the aging male gonadal axis via a biomathematical construct. Am J Physiol Regul Integr Comp Physiol 280: R1755-R1771, 2001.
25. Keenan DM and Veldhuis JD. Divergent gonadotropin-gonadal dose-responsive coupling in healthy young and aging men. Am J Physiol Regul Integr Comp Physiol 286: R381-R389, 2004.
26. Kolp LA, Pavlou SN, Urban RJ, Rivier JC, Vale WW, and Veldhuis JD. Abrogation by a potent GnRH antagonist of the estrogen/progesterone-stimulated surge-like release of LH and FSH in postmenopausal women. J Clin Endocrinol Metab 75: 993-997, 1992.
27. Kuehl RO. Split-Plot Designs. Statistical Principles of Research Design and Analysis. Belmont, CA: Duxbury, 1994, 473-498.
28. Lee S, Miselis R, and Rivier C. Anatomical and functional evidence for a neural hypothalamic-testicular pathway that is independent of the pituitary. Endocrinology 143: 4447-4454, 2002.
29. Liu PY, Swerdloff RS, and Veldhuis JD. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. J Clin Endocrinol Metab 89: 4789-4796, 2004.
30. Longcope C. The effect of human chorionic gonadotropin on plasma steroid levels in young and old men. Steroids 21: 583-592, 1973.
31. Moger WH. Production of testosterone, 5 alpha-androstane-3 alpha, 17 beta-diol and androsterone by dispersed testicular interstitial cells and whole testes in vitro. J Endocrinol 80: 321-332, 1979.
32. Morley JE, Kaiser F, Raum WJ, Perry 3rd HM, Flood JF, Jensen J, Silver AJ, and Roberts E. Potentially predictive and manipulable blood serum correlates of aging in the healthy human male: progressive decreases in bioavailable testosterone, dehydroepiandrosterone sulfate, and the ratio of insulin-like growth factor 1 to growth hormone. Proc Natl Acad Sci USA 94: 7537-7542, 1997.
33. Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, and Veldhuis JD. Amplified nocturnal luteinizing hormone (LH) secretory burst frequency with selective attenuation of pulsatile (but not basal) testosterone secretion in healthy aged men: possible Leydig cell desensitization to endogenous LH signaling-a clinical research center study. J Clin Endocrinol Metab 80: 3025-3031, 1995.
34. Mulligan T, Iranmanesh A, Johnson ML, Straume M, and Veldhuis JD. Aging alters feedforward and feedback linkages between LH and testosterone in healthy men. Am J Physiol Regul Integr Comp Physiol 273: R1407-R1413, 1997.
35. Mulligan T, Iranmanesh A, Kerzner R, Demers LW, and Veldhuis JD. Two-week pulsatile gonadotropin releasing hormone infusion unmasks dual (hypothalamic and Leydig-cell) defects in the healthy aging male gonadotropic axis. Eur J Endocrinol 141: 257-266, 1999.
36. Mulligan T, Iranmanesh A, and Veldhuis JD. Pulsatile iv infusion of recombinant human LH in leuprolide-suppressed men unmasks impoverished Leydig-cell secretory responsiveness to midphysiological LH drive in the aging male. J Clin Endocrinol Metab 86: 5547-5553, 2001.
37. Muta K, Kato K, Akamine Y, and Ibayashi H. Age-related changes in the feedback regulation of gonadotrophin secretion by sex steroids in men. Acta Endocrinol 96: 154-162, 1981.
38. Nankin HR, Lin T, and Murono EP. The aging Leydig cell. III. Gonadotropin stimulation in men. J Androl 2: 181-186, 1981.
39. Neaves WB, Johnson L, Porter JC, Parker, CR Jr, and Petty CS. Leydig cell numbers, daily sperm production, and serum gonadotropin levels in aging men. J Clin Endocrinol Metab 59: 756-763, 1984.
40. Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, and Stallard DJ. Persistence of concordant LH, testosterone and alpha subunit pulses following LHRH antagonist administration in normal men. J Clin Endocrinol Metab 70: 1472-1478, 1990.
41. Pincus SM, Mulligan T, Iranmanesh A, Gheorghiu S, Godschalk M, and Veldhuis JD. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males. Proc Natl Acad Sci USA 93: 14100-14105, 1996.
42. Rabinovici J, Rothman P, Monroe SE, Nerenberg C, and Jaffe RB. Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin- releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women. J Clin Endocrinol Metab 75: 1220-1225, 1992.
43. Reubens R, Dhondt M, and Vermeulen A. Further studies on Leydig cell response to human choriogonadotropin. J Clin Endocrinol Metab 39: 40-45, 1976.
44. Saez JM. Leydig cells: endocrine, paracrine, and autocrine regulation. Endocr Rev 15: 574-626, 1994.
45. Shaar CJ, Euker JS, Riegle GD, and Meites J. Effects of castration and gonadal steroids on serum luteinizing hormone and prolactin in old and young rats. J Endocrinol 66: 45-51, 1974.
46. Sortino MA, Aleppo G, Scapagnini U, and Canonico PL. Different responses of gonadotropin-releasing hormone (GnRH) release to glutamate receptor agonists during aging. Brain Res Bull 41: 359-362, 1996.
47. Stearns EL, MacDonald JA, Kaufman BJ, Padua R, Lucman T, Winter JSD, and Faiman C. Declining testicular function with age, hormonal and clinical correlates. Am J Med 57: 761-766, 1974.
48. Tenover JS, Matsumoto AM, Plymate SR, and Bremner WJ. The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion: response to clomiphene citrate. J Clin Endocrinol Metab 65: 1118-1125, 1987.
49. Urban RJ, Evans WS, Rogol AD, Kaiser DL, Johnson ML, and Veldhuis JD. Contemporary aspects of discrete peak detection algorithms. 1. The paradigm of the luteinizing hormone pulse signal in men. Endocr Rev 9: 3-37, 1988.
50. Veldhuis JD, Cartoon ML, and Johnson ML. The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84: 7686-7690, 1987.
51. Veldhuis JD, Fraioli F, Rogol AD, and Dufau ML. Metabolic clearance of biologically active luteinizing hormone in man. J Clin Invest 77: 1122-1128, 1986.
52. Veldhuis JD and Iranmanesh A. Pulsatile intravenous infusion of recombinant human luteinizing hormone under acute gonadotropin-releasing hormone receptor blockade reconstitutes testosterone secretion in young men. J Clin Endocrinol Metab 89: 4474-4479, 2004.
53. Veldhuis JD, Iranmanesh A, Godschalk M, and Mulligan T. Older men manifest multifold synchrony disruption of reproductive neurohormone outflow. J Clin Endocrinol Metab 85: 1477-1486, 2000.
54. Veldhuis JD, Iranmanesh A, and Keenan DM. An ensemble perspective of aging-related hypoandrogenemia in men. In: Male Hypogonadism: Basic, Clinical, and Theoretical Principles., edited by Winters SJ. Totowa, NJ: Humana, 2004. p. 261-284.
55. Veldhuis JD, Iranmanesh A, Mulligan T, and Pincus SM. Disruption of the young-adult synchrony between luteinizing hormone release and oscillations in follicle-stimulating hormone, prolactin, and nocturnal penile tumescence (NPT) in healthy older men. J Clin Endocrinol Metab 84: 3498-3505, 1999.
56. Veldhuis JD and Johnson ML. Cluster analysis: a simple, versatile and robust algorithm for endocrine pulse detection. Am J Physiol Endocrinol Metab 250: E486-E493, 1986.
57. Veldhuis JD and Johnson ML. Specific methodological approaches to selected contemporary issues in deconvolution analysis of pulsatile neuroendocrine data. Methods Neurosci 28: 25-92, 1995.
58. Veldhuis JD, Urban RJ, Beitins I, Blizzard RM, Johnson ML, and Dufau ML. Pathophysiological features of the pulsatile secretion of biologically active luteinizing hormone in man. J Steroid Biochem 33: 739-750, 1989.
59. Veldhuis JD, Urban RJ, Lizarralde G, Johnson ML, and Iranmanesh A. Attenuation of luteinizing hormone secretory burst amplitude is a proximate basis for the hypoandrogenism of healthy aging in men. J Clin Endocrinol Metab 75: 52-58, 1992.
60. Veldhuis JD, Veldhuis NJ, Keenan DM, and Iranmanesh A. Age diminishes the testicular steroidogenic response to repeated intravenous pulses of recombinant human LH during acute GnRH-receptor blockade in healthy men. Am J Physiol Endocrinol Metab 288: E775-E781, 2005.
61. Veldhuis JD, Zwart A, Mulligan T, and Iranmanesh A. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men. J Clin Endocrinol Metab 86: 529-535, 2001.
62. Vermeulen A, Deslypere JP, and De Meirleir K. A new look at the andropause: altered function of the gonadotrophs. J Steroid Biochem 32: 163-165, 1989.
63. Voglmayr JK, Roberson C, and Musto NA. Comparison of androgen levels in ram rete testis fluid, testicular lymph and spermatic venous blood plasma: evidence for a regulatory mechanism in the seminiferous tubules. Biol Reprod 23: 29-39, 1980.
64. Winters SJ, Sherins RJ, and Troen P. The gonadotropin-suppressive activity of androgen is increased in elderly men. Metabolism 33: 1052-1059, 1984.
65. Winters SJ and Troen P. Episodic luteinizing hormone (LH) secretion and the response of LH and follicle-stimulating hormone to LH-releasing hormone in aged men: evidence for coexistent primary testicular insufficiency and an impairment in gonadotropin secretion. J Clin Endocrinol Metab 55: 560-565, 1982.
66. Zhang FP, Pakarainen T, Poutanen M, Toppari J, and Huhtaniemi I. The low gonadotropin-independent constitutive production of testicular testosterone is sufficient to maintain spermatogenesis. Proc Natl Acad Sci USA 100: 13692-13697, 2003.
67. Zwart AD, Urban RJ, Odell WD, and Veldhuis JD. Contrasts in the gonadotropin-releasing dose-response relationships for luteinizing hormone, follicle-stimulating hormone, and alpha-subunit release in young versus older men: appraisal with high-specificity immunodiometric assay and deconvolution analysis. Eur J Endocrinol 135: 399-406, 1996.